These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

651 related items for PubMed ID: 14991769

  • 1. Latent membrane protein 1 of Epstein-Barr virus plays an important role in the serum starvation resistance of Epstein-Barr virus-immortalized B lymphocytes.
    Park CH, Kim HR, Kim J, Jang SH, Lee KY, Chung GH, Jang YS.
    J Cell Biochem; 2004 Mar 01; 91(4):777-85. PubMed ID: 14991769
    [Abstract] [Full Text] [Related]

  • 2. A role for cell cycle proteins in the serum-starvation resistance of Epstein-Barr virus immortalized B lymphocytes.
    Kim HR, Jeong JA, Park CH, Lee SK, Lee WK, Jang YS.
    Biochem Cell Biol; 2002 Mar 01; 80(4):407-13. PubMed ID: 12234093
    [Abstract] [Full Text] [Related]

  • 3. Latent membrane protein-1 induces cyclin D2 expression, pRb hyperphosphorylation, and loss of TGF-beta 1-mediated growth inhibition in EBV-positive B cells.
    Arvanitakis L, Yaseen N, Sharma S.
    J Immunol; 1995 Aug 01; 155(3):1047-56. PubMed ID: 7636179
    [Abstract] [Full Text] [Related]

  • 4. Cell cycle arrest and lytic induction of EBV-transformed B lymphoblastoid cells by a histone deacetylase inhibitor, Trichostatin A.
    Seo JS, Cho NY, Kim HR, Tsurumi T, Jang YS, Lee WK, Lee SK.
    Oncol Rep; 2008 Jan 01; 19(1):93-8. PubMed ID: 18097580
    [Abstract] [Full Text] [Related]

  • 5. Expression of the Epstein-Barr virus (EBV)-encoded membrane antigen (LMP) increases the stimulatory capacity of EBV-negative B lymphoma lines in allogeneic mixed lymphocyte cultures.
    Cuomo L, Trivedi P, Wang F, Winberg G, Klein G, Masucci MG.
    Eur J Immunol; 1990 Oct 01; 20(10):2293-9. PubMed ID: 2173662
    [Abstract] [Full Text] [Related]

  • 6. Epstein-barr virus can infect B-chronic lymphocytic leukemia cells but it does not orchestrate the cell cycle regulatory proteins.
    Maeda A, Bandobashi K, Nagy N, Teramoto N, Gogolák P, Pokrovskaja K, Székely L, Björkholm M, Klein G, Klein E.
    J Hum Virol; 2001 Oct 01; 4(5):227-37. PubMed ID: 11907380
    [Abstract] [Full Text] [Related]

  • 7. [Studies on transforming functions of Epstein-Barr virus-specific proteins].
    Kinoshita T.
    Hokkaido Igaku Zasshi; 1990 Jul 01; 65(4):362-75. PubMed ID: 2172130
    [Abstract] [Full Text] [Related]

  • 8. Expression of the simian Epstein-Barr virus-encoded latent membrane protein-1 in malignant lymphomas of SIV-infected rhesus macaques.
    Blaschke S, Hannig H, Buske C, Kaup FJ, Hunsmann G, Bodemer W.
    J Med Virol; 2001 Sep 01; 65(1):114-20. PubMed ID: 11505452
    [Abstract] [Full Text] [Related]

  • 9. Multiple signal transducers and activators of transcription are induced by EBV LMP-1.
    Zhang L, Hong K, Zhang J, Pagano JS.
    Virology; 2004 May 20; 323(1):141-52. PubMed ID: 15165826
    [Abstract] [Full Text] [Related]

  • 10. Epstein-Barr virus exploits the normal cell pathway to regulate Rb activity during the immortalisation of primary B-cells.
    Cannell EJ, Farrell PJ, Sinclair AJ.
    Oncogene; 1996 Oct 03; 13(7):1413-21. PubMed ID: 8875979
    [Abstract] [Full Text] [Related]

  • 11. Cytokine mediated induction of the major Epstein-Barr virus (EBV)-encoded transforming protein, LMP-1.
    Kis LL, Takahara M, Nagy N, Klein G, Klein E.
    Immunol Lett; 2006 Apr 15; 104(1-2):83-8. PubMed ID: 16386314
    [Abstract] [Full Text] [Related]

  • 12. Levels of p53 in Epstein-Barr virus-infected cells determine cell fate: apoptosis, cell cycle arrest at the G1/S boundary without apoptosis, cell cycle arrest at the G2/M boundary without apoptosis, or unrestricted proliferation.
    Chen W, Huang S, Cooper NR.
    Virology; 1998 Nov 25; 251(2):217-26. PubMed ID: 9837785
    [Abstract] [Full Text] [Related]

  • 13. Functional analysis of the mutated Epstein-Barr virus oncoprotein LMP1(69del): implications for a new role of naturally occurring LMP1 variants.
    Larcher C, Bernhard D, Schaadt E, Adler B, Ausserlechner MJ, Mitterer M, Huemer HP.
    Haematologica; 2003 Dec 25; 88(12):1324-35. PubMed ID: 14687985
    [Abstract] [Full Text] [Related]

  • 14. Role of c-myc regulation in Zta-mediated induction of the cyclin-dependent kinase inhibitors p21 and p27 and cell growth arrest.
    Rodriguez A, Jung EJ, Yin Q, Cayrol C, Flemington EK.
    Virology; 2001 Jun 05; 284(2):159-69. PubMed ID: 11384216
    [Abstract] [Full Text] [Related]

  • 15. Modulation of expression of insulin and IGF-I receptor by Epstein-Barr virus and its gene products LMP and EBNA-2 in lymphocyte cell lines.
    Kriauciunas KM, Goldstein BJ, Lipes MA, Kahn CR.
    J Cell Physiol; 1993 Mar 05; 154(3):486-95. PubMed ID: 8382208
    [Abstract] [Full Text] [Related]

  • 16. Early detection of the lytic LMP-1 protein in EBV-infected B-cells suggests its presence in the virion.
    Erickson KD, Martin JM.
    Virology; 1997 Jul 21; 234(1):1-13. PubMed ID: 9234942
    [Abstract] [Full Text] [Related]

  • 17. Human immunodeficiency virus type 1 Tat protein modulates cell cycle and apoptosis in Epstein-Barr virus-immortalized B cells.
    Colombrino E, Rossi E, Ballon G, Terrin L, Indraccolo S, Chieco-Bianchi L, De Rossi A.
    Exp Cell Res; 2004 May 01; 295(2):539-48. PubMed ID: 15093750
    [Abstract] [Full Text] [Related]

  • 18. Cytostatic effect of Epstein-Barr virus latent membrane protein-1 analyzed using tetracycline-regulated expression in B cell lines.
    Floettmann JE, Ward K, Rickinson AB, Rowe M.
    Virology; 1996 Sep 01; 223(1):29-40. PubMed ID: 8806537
    [Abstract] [Full Text] [Related]

  • 19. Influence of Epstein-Barr virus latent gene expression on the apoptosis-inducing effects of cortisone and 2-chlorodeoxyadenosine (2-CDA) in B-cell lines.
    Röth A, Pfaff P, Lange W, Finke J.
    Cytokines Mol Ther; 1996 Mar 01; 2(1):21-8. PubMed ID: 9384686
    [Abstract] [Full Text] [Related]

  • 20. Upregulation of Epstein-Barr virus-encoded latent membrane protein by human herpesvirus 6 superinfection of EBV-carrying Burkitt lymphoma cells.
    Cuomo L, Trivedi P, de Grazia U, Calogero A, D'Onofrio M, Yang W, Frati L, Faggioni A, Rymo L, Ragona G.
    J Med Virol; 1998 Jul 01; 55(3):219-26. PubMed ID: 9624610
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.